Physician profile
Robert R Duran
NPI 1053317297
$5,795.47
in general payments reported to CMS, 2019-2025
12 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,783 · 2020: $18.28 · 2022: $347 · 2023: $314 · 2024: $23.31 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,921.54 | 2019-2023 | Da Vinci Surgical System |
| Silk Road Medical, INC. | $174.88 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Bolton Medical INC | $144.90 | 2025 | Gelweave, Relay Thoracic Stent-Graft With Plus Delivery System |
| Relievant Medsystems, INC. | $132.92 | 2022 | |
| Boston Scientific Corporation | $131.41 | 2022 | |
| Imperative Care, INC | $81.73 | 2025 | Symphony Catheter |
| Ethicon US, LLC | $49.72 | 2022-2025 | Proximate, Echelon; Endopath, Echelon Endopath |
| Foundation Fusion Solutions, LLC | $47.06 | 2022 | |
| Bard Peripheral Vascular, INC. | $46.61 | 2025 | Fluency Endovascular Stent Graft |
| Conmed Corporation | $23.31 | 2024 | Airseal |
| Cook Medical LLC | $23.11 | 2022 | |
| Philips North America LLC | $18.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Duran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.